Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam · Delayed Price · Currency is VND 12,400
0.00 (0.00%)
At close: Nov 3, 2026
Vimedimex Medi-Pharma JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 191,459 | 254,764 | 254,764 | 262,485 | 322,702 | 548,130 | |
Market Cap Growth | -23.93% | 0% | -2.94% | -18.66% | -41.13% | 65.12% |
Enterprise Value | -36,047 | -34,021 | 84,183 | 68,425 | 845,554 | 674,751 |
Last Close Price | 12400.00 | 14343.14 | 14343.14 | 13258.21 | 14804.41 | 23745.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.17 | 6.01 | 11.57 | 10.30 | 9.27 | 27.41 |
PS Ratio | 0.62 | 0.31 | 0.20 | 0.07 | 0.05 | 0.04 |
PB Ratio | 0.32 | 0.48 | 0.61 | 0.62 | 0.77 | 1.38 |
P/TBV Ratio | 0.47 | 0.71 | 0.83 | 0.81 | 0.97 | 1.76 |
P/FCF Ratio | - | 24.12 | 2.28 | 47.36 | 0.46 | - |
P/OCF Ratio | - | 24.12 | 2.15 | 12.00 | 0.46 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | 0.07 | 0.02 | 0.12 | 0.06 |
EV/EBITDA Ratio | - | - | 3.35 | 1.27 | 16.45 | 3.93 |
EV/EBIT Ratio | - | - | 15.31 | 1.95 | 26.30 | 4.42 |
EV/FCF Ratio | - | - | 0.75 | 12.35 | 1.21 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | - | - | - | 1.54 |
Debt / EBITDA Ratio | - | - | - | - | - | 3.56 |
Net Debt / Equity Ratio | -0.67 | -0.66 | -0.80 | -0.59 | -0.61 | 1.09 |
Net Debt / EBITDA Ratio | -4.89 | -7.57 | -13.33 | -4.64 | -4.99 | 2.52 |
Net Debt / FCF Ratio | 31.35 | -33.47 | -3.00 | -45.01 | -0.37 | -0.98 |
Asset Turnover | 0.18 | 0.48 | 0.82 | 1.44 | 1.65 | 1.78 |
Inventory Turnover | 16.29 | 14.01 | 6.81 | 5.46 | 3.75 | 3.57 |
Quick Ratio | 22.67 | 1.58 | 1.10 | 0.92 | 0.60 | 0.46 |
Current Ratio | 23.04 | 1.65 | 1.28 | 1.15 | 1.08 | 1.03 |
Return on Equity (ROE) | 13.38% | 8.94% | 5.62% | 6.73% | 8.62% | 5.22% |
Return on Assets (ROA) | 2.80% | 1.58% | 0.22% | 0.89% | 0.47% | 1.38% |
Return on Invested Capital (ROIC) | 34.51% | 25.85% | 3.34% | 14.81% | 4.81% | 17.54% |
Return on Capital Employed (ROCE) | 5.90% | 2.30% | 1.30% | 7.90% | 7.30% | 36.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 31.56% | 16.63% | 9.10% | 9.71% | 10.79% | 3.65% |
FCF Yield | -6.61% | 4.15% | 43.83% | 2.11% | 215.96% | -80.73% |
Dividend Yield | 16.13% | 12.12% | - | - | - | - |
Payout Ratio | 51.11% | - | 135.56% | 118.43% | 43.41% | 200.38% |
Buyback Yield / Dilution | -0.01% | - | 0.02% | -0.02% | 0.00% | 0.00% |
Total Shareholder Return | 16.12% | 12.12% | 0.02% | -0.02% | - | - |